Executive Summary Hematologic Malignancies Market Market Size and Share Across Top Segments The global Hematologic Malignancies market was valued at USD 81.74 billion in 2024 and is expected to reach USD 191.11 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 11.20%, primarily driven by the rising incidence...